← Back to Search

Weight Loss App for Obesity

N/A
Recruiting
Led By Marya Schulte, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to develop an app to help with weight loss for obese adolescents, based on displacement theory to help with addictive behaviors.

Who is the study for?
This trial is for adolescents aged 14-18 with obesity (BMI ≥95th percentile) who are motivated to lose weight, can read and speak English, and have access to an iPhone. They should not be on weight-altering medications or have certain medical conditions like Prader-Willi Syndrome. Those already in another weight loss program or with psychiatric conditions that could interfere with the study cannot join.
What is being tested?
The BrainWeighve app, based on displacement theory, is being tested as a tool for managing obesity in teenagers. The study involves beta testing by groups of teens followed by a four-month trial period where engagement, satisfaction, and the app's impact on clinical outcomes such as weight/BMI and food-related addictive behaviors will be evaluated.
What are the potential side effects?
Since this intervention involves using an app rather than medication or invasive procedures, traditional side effects are not expected. However, participants may experience frustration or lack of interest if they do not find the app engaging.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Quality of Engagement with App
Quantity of Engagement with App
Satisfaction with the App as assessed by the Treatment Satisfaction Questionnaire
Secondary study objectives
%BMI95
Automated Self-Administered 24-Hour Dietary Assessment Tool
Distress Tolerance Scale
+7 more
Other study objectives
Reach and Retention Rates

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: BrainWeighve InterventionExperimental Treatment1 Intervention
4-month smartphone-based weight loss intervention for teens based on displacement theory of addictive behaviors

Find a Location

Who is running the clinical trial?

eHealth International, INC.UNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Weight Loss
20 Patients Enrolled for Weight Loss
Children's Hospital Los AngelesOTHER
249 Previous Clinical Trials
5,074,628 Total Patients Enrolled
2 Trials studying Weight Loss
361 Patients Enrolled for Weight Loss
University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,314,243 Total Patients Enrolled
9 Trials studying Weight Loss
547 Patients Enrolled for Weight Loss
Marya Schulte, PhDPrincipal InvestigatorUniversity of California, Los Angeles

Media Library

BrainWeighve App Clinical Trial Eligibility Overview. Trial Name: NCT05530538 — N/A
Weight Loss Research Study Groups: BrainWeighve Intervention
Weight Loss Clinical Trial 2023: BrainWeighve App Highlights & Side Effects. Trial Name: NCT05530538 — N/A
BrainWeighve App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05530538 — N/A
~12 spots leftby Jun 2025